Cargando…
Potential utility of natural products as regulators of breast cancer-associated aromatase promoters
Aromatase, the key enzyme in estrogen biosynthesis, converts androstenedione to estrone and testosterone to estradiol. The enzyme is expressed in various tissues such as ovary, placenta, bone, brain, skin, and adipose tissue. Aromatase enzyme is encoded by a single gene CYP 19A1 and its expression i...
Autores principales: | Khan, Shabana I, Zhao, Jianping, Khan, Ikhlas A, Walker, Larry A, Dasmahapatra, Asok K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3142499/ https://www.ncbi.nlm.nih.gov/pubmed/21693041 http://dx.doi.org/10.1186/1477-7827-9-91 |
Ejemplares similares
-
Gene expression profiling and pathway analysis data in MCF-7 and MDA-MB-231 human breast cancer cell lines treated with dioscin
por: Aumsuwan, Pranapda, et al.
Publicado: (2016) -
Studies on Pharmacokinetic Drug Interaction Potential of Vinpocetine
por: Manda, Vamshi K., et al.
Publicado: (2015) -
Evaluation of drug interaction potential of Labisia pumila (Kacip Fatimah) and its constituents
por: Manda, Vamshi K., et al.
Publicado: (2014) -
In search for potential antidiabetic compounds from natural sources: docking, synthesis and biological screening of small molecules from Lycium spp. (Goji)
por: Yalamanchili, Chinni, et al.
Publicado: (2019) -
Clinical utilities of aromatase inhibitors in breast cancer
por: Chumsri, Saranya
Publicado: (2015)